Glenmark Pharmaceuticals Inc., USA is voluntarily recalling approximately 3,264 bottles of Diltiazem Hydrochloride Extended-Release Capsules, USP (120 mg). This medication, which is used to treat high blood pressure and chest pain, is being recalled because it failed dissolution specifications during quality testing. Consumers who are currently taking this medication should contact their healthcare provider or pharmacist for further guidance.
If a medication fails to dissolve as specified, the drug may not be absorbed correctly by the body. This can result in the medication being less effective at managing heart conditions and blood pressure.
You have 2 options:
Manufactured for Glenmark Pharmaceuticals Inc., USA. Product of India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.